Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Allerex Laboratory was a Canadian biotechnology company specializing in the development and manufacture of allergenic extracts for diagnostic and therapeutic use. The company's primary focus was on providing allergists with the tools necessary for skin prick testing and subcutaneous immunotherapy (SCIT). Its product catalog included a diverse array of extracts derived from pollens, dust mites, animal epithelia, and fungi. Allerex was eventually acquired by Greer Laboratories, a leader in the allergy immunotherapy space, and its operations were integrated into the broader Stallergenes Greer organization. The company played a significant role in the Canadian allergy market by supplying standardized reagents for clinical practice.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Allerex Laboratory.